Drug recall · November 8, 2017
Clofarabine injection recall
Why: Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.
- Lots / codes
Lot #: K5006Y02, Exp 31AUG18
- Quantity
- 422 vials
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Nationwide in the USA
- Initiated
- October 13, 2017 · Voluntary: Firm initiated
- Classified
- October 30, 2017
- Reported
- November 8, 2017
- Ended
- May 13, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clofarabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.